INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 113 filers reported holding INTERSECT ENT INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,390,000 | +89.4% | 121,032 | +84.6% | 0.01% | +100.0% |
Q4 2021 | $1,790,000 | +248.2% | 65,558 | +118.0% | 0.00% | +50.0% |
Q2 2021 | $514,000 | +102.4% | 30,076 | +93.1% | 0.00% | 0.0% |
Q3 2020 | $254,000 | -89.4% | 15,577 | -81.6% | 0.00% | -91.7% |
Q4 2018 | $2,392,000 | -47.5% | 84,886 | -46.5% | 0.02% | +26.3% |
Q3 2018 | $4,560,000 | -11.1% | 158,598 | -47.4% | 0.02% | -92.3% |
Q1 2017 | $5,129,000 | +1290.0% | 301,698 | +1455.1% | 0.25% | +6100.0% |
Q1 2016 | $369,000 | – | 19,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |